• Sana Shaikh, Gonzalo Matzumura Umemoto, and Anitha Vijayan.
• Division of Nephrology, Washington University in St. Louis, St. Louis, MO.
• Adv Chronic Kidney Dis. 2020 Sep 1; 27 (5): 377-382.

AbstractAcute kidney injury is a common complication in hospitalized patients with coronavirus disease 2019. Similar to acute kidney injury associated with other conditions such as sepsis and cardiac surgery, morbidity and mortality are much higher in patients with coronavirus disease 2019 who develop acute kidney injury, especially in the intensive care unit. Management of coronavirus disease 2019-associated acute kidney injury with kidney replacement therapy should follow existing recommendations regarding modality, dose, and timing of initiation. However, patients with coronavirus disease 2019 are very hypercoagulable, and close vigilance to anticoagulation strategies is necessary to prevent circuit clotting. During situations of acute surge, where demand for kidney replacement therapy outweighs supplies, conservative measures have to be implemented to safely delay kidney replacement therapy. A collaborative effort and careful planning is needed to conserve dialysis supplies, to ensure that treatment can be safely delivered to every patient who will benefit for kidney replacement therapy.Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

36 keywords...

hide…